Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianji Decoction is a traditional Chinese medicine (TCM) herbal formulation developed by Shijiazhuang TCM Hospital. It is primarily investigated for the treatment of sarcopenia in elderly patients, particularly those suffering from osteoporotic vertebral compression fractures (OVCF) who are undergoing percutaneous vertebral augmentation. The decoction is typically administered orally in combination with resistance training to enhance skeletal muscle mass, improve physical function, and modulate bone metabolism. In the context of TCM, the formulation is likely designed to address deficiencies associated with aging, muscle wasting, and bone loss. Clinical evaluation focuses on its ability to improve pain scores, CT imaging parameters, and overall disability in the target population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianji Decoction.